Metabolic disorders, such as T2D or obesity (estimated by waist circumference), and higher ALT values were identified as independent risk factors for MASLD and MASLD-associated significant fibrosis amongst the prison population. The gene discussed is GPT; the disease is type 2 diabetes mellitus.